A $10,000 investment in Oracle (NYSE: ORCL) made one year ago is worth approximately $6,300 today, with dividends included in that calculation.
The stock closed at $248.28 on August 15, 2025, and now trades at around $154, representing a decline of roughly 38% over the 12-month period.
That single figure, however, does little justice to the extraordinary volatility investors endured throughout the year.
Within just one month of that hypothetical purchase, the same $10,000 stake briefly ballooned to nearly $14,000 as market enthusiasm surged around the company.
By late July of this year, that same position had collapsed to approximately $4,600, wiping out gains and then some in a dramatic reversal.
Few companies of Oracle’s size have traveled that far in both directions within a single 12-month window, making it one of the more turbulent rides among large-cap technology stocks.
The inflection point came on September 9, 2025, when Oracle reported its fiscal 2026 first-quarter results, fundamentally shifting how the market assessed the company’s trajectory.
Revenue grew 12% during that quarter, a solid if unremarkable figure, but it was the remaining performance obligations number that truly captured investor attention.
Remaining performance obligations, which represent contracted future revenue, surged from $455 billion in September 2025 to $638 billion by the close of fiscal 2026, signaling enormous forward demand.
That demand has come at a steep cost, with Oracle reporting $21 billion in capital expenditures the prior year before that figure ballooned to $55 billion in fiscal 2026.
The aggressive spending left Oracle with negative cash flow of $23.7 billion in fiscal 2026, a figure that reflects the scale of infrastructure investment now underway at the company.
To sustain that investment pace, Oracle has announced plans to raise an additional $40 billion through debt and equity financing in fiscal 2027, adding further pressure on the balance sheet.
The combination of mounting debt, heavy capital expenditure, and a sharp share price decline has raised legitimate questions among investors about whether Oracle’s growth ambitions are being priced correctly by the market.
